Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial
Myung Chul Yoo(Kyung Hee University), Yan Li(Shanxi Medical University), Yong-Wook Park(Chonnam National University Hospital), Aleksandar Skuban, Seong‐Il Bin(University of Ulsan), Diane M. Cukrow(Merck & Co., Inc., Rahway, NJ, USA (United States)), Seong-Hwan Moon(Yonsei University), Yeong Wook Song(AbbVie (United States)), Yoon Je Cho(Kyung Hee University Medical Center), Anish Mehta(Merck & Co., Inc., Rahway, NJ, USA (United States)), Dae‐Hyun Yoo(Hanyang University Seoul Hospital), Sung-Soo Kim(Ulsan College), Sung Won Lee(Pusan National University Hospital), Han-Joo Baek(Deleted Institution), Kristel Vandormael(Merck & Co., Inc., Rahway, NJ, USA (United States)), Byung Woo Min(Keimyung University Dongsan Medical Center), Seung Baek Kang(SNUH SMG-SNU Boramae Medical Center), Seung Cheol Shim(Chungnam National University Hospital), Wan Hee Yoo(Jeonbuk National University Hospital), Kyoung Ho Moon(Inha University Hospital)
Cited by 15
Related Papers
Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models
|Arthritis Research & Therapy|2009|392
High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry
|Nature Genetics|2016|269
Association of Genetic Variants in Complement Factor H and Factor H-Related Genes with Systemic Lupus Erythematosus Susceptibility
|PLoS Genetics|2011|231
Mucosal-Associated Invariant T Cell Deficiency in Systemic Lupus Erythematosus
|The Journal of Immunology|2014|189
Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus
|Annals of the Rheumatic Diseases|2020|183